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Abstract
NMDA receptors (NMDARs) form glutamate-gated ion channels that play a critical role in CNS physiology and pathology.
Together with AMPA and kainate receptors, NMDARs are known to operate as tetrameric complexes with four membrane-
embedded subunits associating to form a single central ion-conducting pore. While AMPA and some kainate receptors can
function as homomers, NMDARs are obligatory heteromers composed of homologous but distinct subunits, most usually of
the GluN1 and GluN2 types. A fundamental structural feature of NMDARs, that of the subunit arrangement around the ion
pore, is still controversial. Thus, in a typical NMDAR associating two GluN1 and two GluN2 subunits, there is evidence for
both alternating 1/2/1/2 and non-alternating 1/1/2/2 arrangements. Here, using a combination of electrophysiological and
cross-linking experiments, we provide evidence that functional GluN1/GluN2A receptors adopt the 1/2/1/2 arrangement in
which like subunits are diagonal to one another. Moreover, based on the recent crystal structure of an AMPA receptor, we
show that in the agonist-binding and pore regions, the GluN1 subunits occupy a ‘‘proximal’’ position, closer to the central
axis of the channel pore than that of GluN2 subunits. Finally, results obtained with reducing agents that differ in their
membrane permeability indicate that immature (intracellular) and functional (plasma-membrane inserted) pools of NMDARs
can adopt different subunit arrangements, thus stressing the importance of discriminating between the two receptor pools
in assembly studies. Elucidating the quaternary arrangement of NMDARs helps to define the interface between the subunits
and to understand the mechanism and pharmacology of these key signaling receptors.
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Introduction
Ionotropic glutamate receptors (iGluRs) mediate most excitato-
ry neurotransmission in the vertebrate brain and function by
opening a transmembrane ion channel upon binding of glutamate.
The iGluRs are critical for normal brain function and de-
velopment, and their dysfunction is implicated in numerous
neurological and psychiatric disorders [1]. Based on sequence
homology and pharmacology, iGluRs can be grouped into three
main subfamilies: AMPA-, kainate- and NMDA-type, the latter
being unique in its ability to flux calcium and trigger synaptic
plasticity mechanisms [1]. Since the cloning of iGluR subunits
some twenty years ago, a wealth of information regarding iGluR
structure and mechanism of operation has been obtained [2,3].
Unlike other ionotropic neurotransmitter receptors that form
either pentamers (Cys-loop receptors) or trimers (P2X receptors),
the iGluRs assemble as tetrameric complexes composed of four
homologous pore-forming subunits. All iGluR subunits share
a unique modular architecture consisting of a large extracellular
N-terminal domain (NTD) that participates in subtype-specific
assembly and modulation; an agonist-binding domain (ABD also
known as S1S2) that binds glutamate (or glycine/D-serine in
certain NMDAR subunits); a transmembrane domain (TMD)
comprising three membrane spanning segments (M1, M3 and M4)
plus a short re-entrant loop (M2) lining the ion selectivity filter;
and a cytoplasmic C-terminal domain (CTD), variable in length
and involved in receptor trafficking, localization and regulation.
A major breakthrough in the field was recently achieved with
the crystal structure of a homomeric GluA2 AMPAR [4] thus
providing the first atomic map of an intact iGluR. The structure
revealed a massive Y-shaped structure in which the three major
domains are arranged in layers: at the narrow ‘‘base’’, the TMDs,
at the ‘‘top’’ the NTDs and sandwiched in between these two
layers the ABDs. As anticipated from studies on isolated domains
[3], the extracellular NTD and ABD both assemble in the full
length structure as dimers of dimers but with surprisingly few
contacts between the four constitutive dimers. The pore region, in
contrast, adopts a more compact structure with the typical four-
fold symmetrical architecture found in potassium channels.
Accompanying the two-fold to four-fold symmetry transition
between the extracellular and pore regions, another key feature
revealed by the GluA2 structure is domain swapping. Thus, local
dimer assemblies in the NTD and ABD layers engage different
subunit pairs. As a consequence of domain swapping and
symmetry mismatch, the four chemically-identical GluA2 subunits
adopt two pairs of conformationally distinct subunits, A/CandB/
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35134D (Fig. 1; [4]), with like conformers diagonal to one another. At the
NTDlayer,theA/Csubunitsaremore‘‘distal’’fromthecentralaxis
oftheporethantheB/Dsubunits,whileattheABDlayer, the A/C
subunits occupy a more ‘‘proximal’’ position and participate in
a tetrameric (dimer-of-dimers) interface (Fig. 1). Such an
asymmetrical organization is without precedent in other families
of neurotransmitter receptors.
NMDARs and kainate receptors are likely to adopt a general
arrangement similar to that of AMPARs [1,5]. However, unlike
AMPA and kainate receptors that can function as homomers,
NMDARs are obligatory heteromers usually composed of two
GluN1 and two GluN2 subunits of which there are four isoforms
(GluN2A-D) [6]. Although the NTDs and ABDs are likely to
arrange as local GluN1/GluN2 heterodimers [7,8,9,10,11], there
have been diverging results regarding the subunit order around the
pore, with data supporting a 1/2/1/2 [4,12,13] or 1/1/2/2
[14,15] organization. Here, by exploiting disulfide cross-linking to
probe proximity relationships between subunits, we provide
evidence that subunits in a functional GluN1/GluN2A receptor
arrange in a 1/2/1/2 pattern with the GluN1 subunits adopting
the ‘‘proximal’’ A/C conformation in the gating core region. Our
results also highlight the fact that the existence of stable pools of
intracellular GluN1 oligomers is a confounding factor in immuno-
blots studies of NMDARs.
Results
In the closed-state GluA2 structure, symmetry mismatch
between the ABD and the TMD levels is mediated primarily by
the short linkers connecting the two domains (S1-M1, M3-S2 and
S2-M4 linkers; ref. [4]). In particular, the M3-S2 linkers adopt two
strikingly different conformations with the linkers from the B/D
subunits stretching away from the pore axis while the linkers from
the A/C subunits remain close and prolong the TM3 segment by
one helical turn (Fig. 2A). Accordingly, a cysteine introduced in
the C-terminal end of TM3 (GluA2-M629C) can participate to
a disulfide bridge in the A/C subunits but is too far removed to
cross-link in the B/D subunits [4]. To explore which of the GluN1
and/or GluN2 subunits display the A/C and B/D conformers in
the ABD-TMD linker region of a GluN1/GluN2A receptor, we
introduced cysteines in GluN1 and GluN2A subunits at positions
homologous to GluA2-M619 (Fig. 2A) and tested for possible
disulfide cross-linking using electrophysiological recordings of
Xenopus oocytes. Current responses from GluN1-P660C/Glu2Awt
or GluN1wt/GluN2A-F658C receptors, and their respective
control (alanine) mutants, were first subjected to the reducing
agent dithioerythritol (DTE). Compared to control mutants, no
significant effect of DTE on cysteine mutants was detected, and
the use of Tris(2-carboxyethyl)phosphine (TCEP) as an alternative
reducing agent confirmed this result (Fig. 2B). This lack of effect
was surprising given that the GluN1-P660C mutation had
previously shown to yield dimers on immunoblots [4,13], and
that cross-linking right next to the channel gate region (the
SYTANLAAF region; ref. [16]) should lock the channels in
a closed state.
Oxidizing treatments using 5,5’-dithiobis-(2-nitrobenzoate)
(DTNB) to promote the formation of disulfide bonds also resulted
in no significant effect on current amplitude. Intriguingly,
however, the oxidizing complex Copper/Phenanthroline (Cu/
Phen) selectively reduced currents carried by GluN1-P660C/
GluN2Awt receptors but not by GluN1wt/GluN2A-F658C
receptors (Fig. 2C). Because cysteines, through their sulfhydryl
moiety, are commonly found in metal-binding sites [17], we
wondered whether the effect of Cu/Phen on GluN1-P660C/
GluN2Awt receptors could be accounted for direct copper
inhibition rather than a redox effect. Incubating in copper alone
Figure 1. Subunit organization of the tetrameric GluA2 AMPA receptor. Side view of the gating core (ABD + TMD) of the GluA2
homotetramer [4]. The subunits adopt two different conformations, A/C (blue) and B/D (red). The insets on the right show how subunits are
organized in the ABD and TMD (pore) layer. The grey shading indicates the two local ABD dimers. The black dot indicates the point of contact
between subunits A and C at the dimer-of-dimers interface in the ABD layer. Numbers 1 and 2 highlight the two regions where mutations have been
introduced in NMDARs.
doi:10.1371/journal.pone.0035134.g001
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rents than with Cu/Phen, and full dose-response curves with
tricine-buffered copper solutions revealed the presence of a very
high-affinity (subnanomolar) copper binding site in receptors
containing the GluN1-P660C subunits (but not the GluN1-P660A
subunits or GluN1wt) and the mutated GluN2A-F658C subunits
(Fig. 2D). Thus, in functional receptors, the two cysteines
introduced at position GluN1-P660 do not disulfide bridge as
previously suggested [4,13] but have their thiol groups in close
enough vicinity to participate in a copper coordinating site.
Altogether these results strongly favor a model in which, in the
ABD-TMD linker region, the two GluN1 subunits occupy the
proximal A/C positions while the GluN2 subunits occupy the
more distal B/D position. Incidentally, we suggest that the
reversion of the Cu/Phen effects on certain GluN1 cysteine pore
mutants observed by Salussolia et al. [13] upon application of
DTT may result from copper chelation rather than from a bona
fide redox effect (see ref. [18] for the metal chelating properties of
DTT).
We next introduced cysteines in the ABD layer to map contact
points between neighboring subunits. Guided by the superposition
of the GluN1/GluN2A ABD heterodimer onto the GluA2
structure (Fig. 3A), we focused on several residues in helices E
and G of GluN1 and GluN2A subunits that could potentially
participate in a dimer-of-dimers interface. At the level of this
interdimer interface, three types of contacts can be envisioned
according to the different possible arrangements of the two
heterodimers in the tetrameric assembly: heterophilic GluN1-
GluN2 contacts or homophilic GluN1-GluN1 or GluN2-GluN2
contacts (Fig 3A and see ref. [4]). To check for potential functional
effects of cysteine introduction in the ABD region, we assessed the
channel activity of mutated receptors by measuring the inhibition
kinetics produced by the open-channel blocker MK-801 [19]. Of
the several cysteine substitutions that were investigated, only
GluN1-E698C/GluN2Awt mutant receptors showed a markedly
altered (decreased) channel activity, as revealed by the 1.85-fold
increase in MK-801 inhibition time constant compared with wild-
type receptors (Fig. 3B). No such effect was observed with the
control GluN1-E698A mutation (Fig. 3C). Moreover, channel
activity could be further diminished (i.e. MK-801 inhibition time
constant increased) by applying an oxidizing treatment, while
a subsequent reducing treatment led to a strong increase in
channel activity to a value close to that of untreated GluN1-
E698A/GluN2Awt receptors (Fig. 3C). Thus, introduction of
a single cysteine in the GluN1 subunit at position E698 is sufficient
to result in disulfide bond formation. We also evaluated the effects
of redox treatments on the activity of GluN1wt/GluN2A-Q671C
receptors. In contrast to the effects previously described with the
GluN1 mutant receptor, no effect specific to the GluN2A cysteine
mutant was detected (Fig. 3C). These results indicate that within
the ABD layer of functional GluN1/GluN2A receptors, residues
from the GluN1 subunit ABD S2 region, but not the homologous
region of the GluN2A subunit, participate in an interdimer
interface. Thus, in a tetrameric GluN1/GluN2A assembly, the
GluN1 subunits likely adopt the proximal A/C conformer at the
ABD level, while the GluN2A subunits would adopt the more
distal B/D configuration.
We obtained additional functional evidence that residue GluN1-
E698 is involved in subunit-subunit contacts by reacting reduced
(TCEP-treated) GluN1-E698C/GluN2Awt receptors with the
thiol-specific modifying reagent MTSET. MTSET induced
a marked and irreversible inhibition of currents from the cysteine
Figure 2. Insertion of a single cysteine in the GluN1 M3-S2 linker results in the creation of a high-affinity copper binding site. (A) The
ion-channel (M3 and M3-S2 linkers) region of a modelled tetrameric GluN1/GluN2A receptor viewed from the side (left) and from above the
membrane plane (right). In this alternating model (GluN1/2/1/2), the two GluN1 subunits (blue) are in the ‘‘proximal’’ A/C conformation and the two
GluN2A subunits (red) in the ‘‘distal’’ B/D conformation. Homologous mutations GluN1-P660C and GluN2A-F658C are highlighted (sulphur in yellow).
(B and C) Effects of reducing (B) and oxidizing (C) treatments on current amplitudes of the various cysteine (filled bars) or alanine (empty bars)
mutant receptors. Values in B are (from left to right): 1.08 6 0.05 (n=8), 0.96 6 0.15 (n=7), 1.35 6 0.2 (n=14), 1.38 6 0.16 (n=8), 1.05 6 0.22 (n=9),
1.05 6 0.06 (n=11), 1.35 6 0.16 (n=20), 1.49 6 0.2 (n=6). Values in C are (from left to right): 1.18 6 0.18 (n=32), 1.09 6 0.08 (n=8), 1.1 6 0.11
(n=13), 1.13 6 0.08 (n=4), 0.51 6 0.11 (n=28), 0.90 6 0.15 (n=19), 0.65 6 0.15 (n=20) and 0.56 6 0.08 (n=8). (D) Copper inhibition dose-response
curves for wild-type (open circles; Inhibmax = 21%, IC50 = 0.19 nM, nH = 1.3), GluN1wt/GluN2A-F658C (open squares; Inhibmax = 34%, IC50 =
0.33 nM, nH = 0.7), GluN1-P660C/GluN2Awt (filled circles; Inhibmax = 78%, IC50 = 0.075 nM, nH = 3) and GluN1-P660A/GluN2Awt receptors (filled
squares; Inhibmax = 15%, IC50 = 0.21 nM, nH = 1.5). Right: current traces illustrating the inhibition of GluN1-P660A/GluN2Awt (top) and GluN1-
P660C/GluN2Awt (bottom) receptors by 0.3 nM free copper. *** corresponds to P,0.001; ns, non-significant; Student’s t-test.
doi:10.1371/journal.pone.0035134.g002
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PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e35134Figure 3. Disulfide cross-linking at the putative ABD dimer-of-dimers interface between GluN1, but not GluN2A, subunits. (A) Three
possible arrangements viewed from the membrane region of GluN1/GluN2A ABD heterodimers in a NMDAR based on GluA2 structure. Mutated
residues GluN1-E698 and GluN2A-Q671 are highlighted in blue and red, respectively. The residues either lie at the dimer-of-dimers interface in the
proximal A/C subunits or protrude towards the exterior surface of the receptor in the distal B/D subunits. (B) MK-801 inhibition kinetics for various
GluN1 (top) and GluN2A (bottom) mutants. Values are (from left to right): 0.9 6 0.04 (n=5), 0.93 6 0.09 (n=9), 1.85 6 0.13 (n=20), 0.91 6 0.05
(n=8), and 0.87 6 0.06 (n=7) for GluN1 mutants; 1.17 6 0.15 (n=21), 0.90 6 0.06 (n=11), 0.91 6 0.09 (n=11) and 0.87 6 0.1 (n=11) for GluN2A
mutants. All GluN1 mutant subunits were co-injected with GluN2A wt and all GluN2A mutant subunits with GluN1 wt. (C) Effects of redox treatments
on the MK-801 inhibition kinetics for cysteine (filled bars) or alanine (empty bars) mutants. Values are (from left to right): control conditions, 1.85 6
0.13 (n= 20), 0.96 6 0.07 (n= 12), 1.17 6 0.15 (n= 21), 1.19 6 0.06 (n= 9); after incubation with Cu/Phen (oxidation): 2.21 6 0.18 (n= 12), 1.07 6
0.07 (n= 10), 1.28 6 0.14 (n= 18), 1.36 6 0.14 (n= 9); after subsequent incubation with TCEP (reduction): 1.31 6 0.18 (n= 19), 0.88 6 0.08 (n= 7),
0.83 6 0.09 (n= 17), 0.86 6 0.11 (n= 9). Inset: MK-801 inhibition kinetics are slower in non-treated GluN1-E698C/GluN2Awt receptors (2) than in non-
treated GluN1-E698A/GluN2Awt receptors (1) or TCEP-treated GluN1-E698C/GluN2Awt receptors (3) (normalized currents). (D) Effects of MTSET
application on current amplitudes for cysteine (filled bars) or alanine (empty bars) mutants. Values are (from left to right): 0.70 6 0.02 (n=18), 0.95 6
0.03 (n=11), 0.95 6 0.04 (n=9) and 0.95 6 0.02 (n=5). Right: current traces illustrating the effects of MTSET on GluN1-E698A/GluN2Awt and GluN1-
E698C/GluN2Awt receptors. *** corresponds to P,0.001; ns, non-significant; Student’s t-test.
doi:10.1371/journal.pone.0035134.g003
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were barely affected. In contrast, no specific effect of MTSET was
observed on GluN1wt/GluN2A-Q671C receptors (Fig. 3D).
We next turned to immunoblot experiments to directly assess
cysteine disulfide cross-linking and intersubunit dimer formation.
We first analyzed mutant receptors composed of wt GluN1
subunits and GluN2A subunits with a cysteine introduced either in
the TM3-S2 linker region or the ABD region. Under non-
reducing conditions, no formation of high-molecular weight bands
was detected for any of the mutant receptors (Fig. 4A). This result
indicates that the introduced cysteines in the GluN2A subunit do
not participate in intersubunit disulfide bond formation, in good
agreement with the results of the functional experiments using
electrophysiology. In contrast, high-molecular weight bands were
clearly detected with receptors harboring a single cysteine
substitution either in the TM3-S2 or ABD region of the GluN1
subunit. These bands were attributed to disulfide cross-linked
GluN1 homodimers since they ran at the expected size
(,220 kDa) and were absent in the control alanine mutants or
in blots performed in reducing conditions (+DTE) (Fig. 4C).
The observation that GluN1-P660C mutant could form
homodimers, while confirming previously published results
[4,13], was clearly at odds with our electrophysiological experi-
ments, which indicate that in functional GluN1-P660C mutant the
introduced cysteines form a metal binding site and not a disulfide
bridge (see Fig. 2). Our 3D model also indicated that the two
engineered cysteines are separated by too great a distance (7 A ˚ S-
S, 12 A ˚ Ca-Ca; Fig. 2A) to cross-link [20,21]. Because in
electrophysiological experiments, only fully-mature plasma-mem-
brane embedded receptors are monitored, we wondered whether
the GluN1-P660C homodimers observed in immunoblots could
be attributed to intracellular pools of cross-linked GluN1
subunits. It is well established that the GluN1 subunit, both in
recombinant and native systems, can form stable intracellular
homo-oligomers while GluN2 subunits do not [22,23,24,25]. To
try to discriminate between intracellular receptors from those
expressed at the cell surface, we compared immunoblots from
cells treated either with DTE or TCEP. Both compounds are
powerful reducing agents but while DTE can cross biological
membranes, TCEP is membrane-impermeant [26] (Fig. 4B). As
shown in Figure 4C, the GluN1-P660C homodimer band was
sensitive to DTE but not to TCEP, suggesting that the GluN1-
P660C homodimers are for the most part localized intracellu-
larly. The situation differed strikingly with the cysteine in-
troduced in the GluN1 ABD at the putative interdimer interface
(GluN1-E698C/GluN2Awt receptors). There, the GluN1-E698C
homodimer band was sensitive to both DTE and TCEP
(Fig. 4C). These results suggest that a sizeable fraction of
GluN1-E698C/GluN2A receptors with disulfide cross-linked
GluN1 subunits are expressed at the plasma membrane. These
results are in good agreement with our previous observations
Figure 4. Intracellular and plasma-membrane pools of disulfide cross-linked receptors. (A) Immunoblots from Xenopus oocytes
expressing either wt or GluN2A mutant receptors. (B) Schematic representation of a cell expressing intracellular and plasma-membrane pools of
receptors with intersubunit disulfide cross-links. Because of their differential membrane permeability, the reducing agent DTE acts on both pools
while the reducing agent TCEP acts solely on the cell surface pool. (C) Immunoblots from oocytes expressing either wt or GluN1 mutant receptors.
(D) Immunoblots from occytes injected either with both GluN1 and GluN2A subunits or with the GluN1 subunit alone. M1 indicates the expected
band position of the GluN1 monomer (,110 kDa); M2, the GluN2A monomer (,180 kDa); D1, the GluN1 homodimer (,220 kDa) and T1 the
approximate location of the GluN1 homo-trimer and/or homo-tetramer (.300 kDa). CC stands for mutations GluN1-N521C-L777C (in ABD intradimer
interface). M stands for molecular weight marker and n.i. for non-injected oocytes. * indicates non-specific bands seen with the anti-GluN1 antibody.
doi:10.1371/journal.pone.0035134.g004
Subunit Arrangement in NMDA Receptors
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e35134that currents carried by GluN1-E698C/GluN2Awt receptors are
redox sensitive (see Fig. 3).
We obtained additional evidence for the validity of our DTE/
TCEP approach by expressing mutated GluN1 subunits alone,
without a co-expressed GluN2 subunit. In this condition, the vast
majority of the GluN1 subunits are known not to traffic to the
plasma membrane but instead remain ‘‘stuck’’ in intracellular
pools [22,23,24]. As anticipated, immunoblots of oocytes expres-
sing the GluN1-E698C subunit alone revealed a GluN1 homo-
dimer band sensitive to DTE but not to TCEP (Fig. 4D). When we
combined the E698C mutation with two additional cysteine
mutations within the ABD intradimer interface (mutations GluN1-
N521C-L777C; refs. [7,8,27]), bands of very high molecular
weight were observed in addition to the homodimer band. Again
these bands were sensitive to DTE but not to TCEP (Fig. 4D).
Thus, the triple cysteine GluN1 mutant subunit can accumulate as
intracellular pools of homotrimers or homotetramers with disulfide
cross-links within and between GluN1 ABD dimers. Noticeably,
when the double mutant GluN1-N521C-L777C subunit was co-
expressed with the wt GluN2A subunit, DTE-sensitive, but TCEP-
insensitive, GluN1 homodimer bands were observed (Fig. 4D).
These bands most likely correspond to intracellular stocks of
GluN1 homodimers with the two GluN1 ABDs cross-linked at the
intradimer interface. Such assemblies are not present in functional
receptors. In these latter, the ABDs arrange as local GluN1/
GluN2 heterodimers [7,8].
Discussion
In the present work we provide biochemical and functional
evidence that mature GluN1/GluN2A NMDARs adopt an
alternating GluN1/2/1/2 subunit arrangement with the two
GluN1 subunits occupying the ‘‘proximal’’ A/C conformation
seen in the AMPAR GluA2 receptor and the two GluN2A
subunits occupying the distinct B/D conformation. Our bio-
chemical approach based on differential detection of disulfide
cross-linked receptors between intracellular and cell surface
receptor pools also reveals that the subunit arrangement can
differ between functional (cell surface) and intracellularly-retained
receptors. In particular, cysteine-engineered GluN1 subunits have
a strong propensity to form oligomeric assemblies that are not
found in mature receptors. Overall, our results buttress previous
findings that NMDAR maturation involves rearrangement of
subunit contacts [25].
The interpretation of our results strongly relies on the
assumption that the general subunit arrangement of NMDARs
resembles that described in the AMPAR GluA2 structure, at least
in the gating core region (ABD + TMD). The overall sequence
homology between iGluR subunits and the striking similarities in
the structure and mechanism of the ABDs between all iGluRs [1]
strongly argue that this likely to be the case. Our present finding
that, based on the GluA2 structure, cysteines (GluN1-E698C)
introduced at a putative ABD tetrameric interface can cross-link
in a mature GluN1/GluN2A receptor and impact its function
(Fig. 3A) provides additional evidence that NMDAR and
AMPAR subunits arrange similarly. It also suggests that in
a NMDAR the ABD tetrameric interface experiences conforma-
tional mobility during receptor gating. Our results reveal that this
interface involves the GluN1, but not the GluN2, subunits.
Moreover, as a consequence of symmetry mismatch between the
ABD and TMD layers, the GluN1 subunits - and more generally
the A/C conformers in an iGluR - are expected to couple
differently to the ion channel gate than the GluN2 subunits (B/D
conformers). As a matter of fact, differential contributions of
GluN1 and GluN2 subunits to NMDAR channel gating have
been reported [28,29,30,31]. The knowledge of the spatial
organization of the subunits within a functional NMDAR
complex provides an essential structural framework to un-
derstand how the four subunits interact and co-operate during
channel gating and modulation.
Materials and Methods
Molecular biology
The expression plasmids for the rat GluN1-1a subunit and the
rat GluN2A subunit, the mutagenesis strategy and sequencing
have been previously described [10,18]. All amino acid (aa)
numbering is for full-length proteins (i.e. including the signal
peptide). For correspondence with other studies not considering
full-length proteins, a difference in the numbering of GluN1 and
GluN2A subunits should be applied (for ref. [13], +18 and +19 aa,
respectively; for ref. [4], -1 and +27 aa, respectively).
Electrophysiological experiments and data analysis
Recombinant NMDARs were expressed in Xenopus laevis
oocytes after nuclear co-injection of cDNAs (at 10-30 ng/ml)
coding for the various GluN1-1a and GluN2A subunits (ratio 1:1).
Oocytes were prepared, injected, voltage-clamped, and superfused
as described previously [18]. The standard external solution
contains (in mM): 100 NaCl, 0.3 BaCl2, 2.5 KCl, 5 HEPES, and
0.01 DTPA (pH 7.3). The heavy metal chelator DTPA (diethy-
lenetriamine-pentaacetic acid) was added to all solutions, except in
copper-containing solutions, to prevent tonic inhibition of GluN1/
GluN2A receptors by trace amounts of zinc [18]. NMDAR-
mediated currents were induced by simultaneous application of
saturating concentrations of L-glutamate and glycine (100 mM
each). Recordings were performed at a holding potential of
260 mV and at room temperature. For copper dose-response
experiments, copper was buffered using 10 mM tricine. For free
copper concentrations of 0.01, 0.03, 0.1, 0.3, 1 and 3 nM, total
(added) concentrations of copper (CuSO4 salt) were (in mM): 2.3,
7.0, 23, 70, 210 and 550, respectively. These values were
calculated using Geochem with stability constants of 10
–7 M and
10




2+ + Tricine ? Tricine2-Cu
2+, respectively [32]. For
the highest concentrations of free copper (1 and 3 nM), pH
was readjusted to 7.3. Experiments using MK-801 (10 nM) and
([2-(Trimethylammonium)ethyl]methane-thiosulfonate bromide)
(MTSET, 200 mM) were performed as described in ref. [10].
Data were collected and analyzed using Clampex 7.0 and
Clampfit 9.2 (Axon Instruments), respectively. For copper dose-
response curves, data points were fitted in Kaleidagraph 4.0
(Synergy Software) using the following Hill equation: ICu/Icontrol
= 0.96-Inhibmax/(1+(IC50/[Cu
2+]
nH), where ICu/Icontrol is the
mean relative current, [Cu
2+] the concentration of free copper, nH
the Hill coefficient and (Inhibmax + 0.04) the maximal copper
inhibition. IC50, Inhibmax and nH were set as free parameters.
Error bars represent the standard deviation of the mean value.
Redox treatments
Oocytes were incubated at room temperature with either
dithioerythritol (DTE, 5 mM, 15 min), tris(2-carboxyethyl)pho-
sphine (TCEP, 5 mM, 15 min), 5,5’-dithio-bis-(2-nitro-benzoic
acid (DTNB, 0.5 mM, 5 min), or copper(II):phenanthroline (Cu/
Phen, 10:30 mM, 12 min), all prepared in a Barth solution
supplemented with gentamycin (50 mg/ml) and D-AP5 (50 mM)
[8]. For DTE and TCEP solutions, pH was adjusted to 8.0. The
DTNB solution was also supplemented with DTPA (10 mM).
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Sample preparation, non-reducing SDS-PAGE, and immuno-
blotting were performed as described in ref. [10]. The following
antibodies were used: anti-GluN1 antibody (1:1000, mouse
monoclonal MAB363 clone 54.1; Millipore), anti-GluN2A
antibody (1:500, rabbit monoclonal A12W; Millipore), secondary
goat peroxidase-conjugated anti-mouse or anti-rabbit antibody
(1:20,000, Jackson ImmunoResearch). Non-specific bands (i.e.
bands detected in immunoblot experiments with non-injected
oocytes), were regularly observed with the anti-GluN1 antibody.
The intensity of these bands varies from one batche of oocytes to
another. The molecular weight of the main non-specific band is
,270 kDa.
Homology modeling
3D homology modeling was performed using the program
Modeller and structure illustrations were prepared using PyMol
and VMD (see ref. [33]). The model of the NMDAR pore
region (Fig. 2A) was built by homology to the GluA2 structure
(pdb 3KG2; ref. [4]) while the three different arrangements of
ABD tetramers (Fig. 3A) were built by superimposing two
GluN1-GluN2A ABD heterodimers (pdb 2A5T; ref. [7]) on the
GluA2 ABD tetramer.
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